Skip to main content
ABCL logo

ABCL · AbCellera Biologics Inc. · Debt

Track ABCL — free
$11.07 -0.37 (-3.23%)
Market Cap
$3.50B
Shares
306.61M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1703057 CUSIP 00288U106 13F (30d) 89 filings 89 filers Visit website Investor relations